The Malawi government has introduced new regulations governing the import and export of medicines. The regulations, published in the November 13, 2026 Malawi Government Gazette Supplement, include the Import Regulations, Export Regulations, and Entry Points Regulations. These regulations were issued by Minister of Health and Sanitation Madalitso Baloyi and operationalize provisions of the Pharmacy and Medicines Regulatory Authority (PMRA) Act, which was enacted by Parliament in 2019.

The regulations require that only pharmacists registered with PMRA, managing pharmaceutical businesses, holding valid wholesale licenses, and possessing relevant permits issued by the authority can import or export medicines. This move aims to regulate the pharmaceutical industry and ensure that only authorized individuals and businesses are involved in the import and export of medicines. The regulations also designate seven border points for pharmaceutical products to enter or leave the country.

The new regulations prescribe penalties for specified offenses, including fines of up to K5 million and imprisonment of up to five years. According to PMRA director general Charles Chimenya, the regulations strengthen the statutory mandate of PMRA to protect public health and prevent the infiltration of falsified and substandard products. This move is expected to improve the quality and safety of medicines available in the country.

Pharmaceutical Society of Malawi president William Mpute welcomed the regulations, describing them as long overdue. He noted that the measures could help address the problem of substandard medicines but emphasized the need for adequate resources to enable the regulator to enforce them effectively. The introduction of these regulations is a significant step towards ensuring that medicines available in Malawi meet international standards.

The regulations are a result of the government's efforts to strengthen the regulatory framework for the pharmaceutical industry. The PMRA Act, which was enacted in 2019, provides the legal framework for regulating the import, export, and distribution of medicines in Malawi. The new regulations provide a clear framework for the implementation of the Act and ensure that the country's pharmaceutical industry is regulated.

The introduction of mandatory inspections of imported medicines is another key aspect of the regulations. This move aims to ensure that medicines entering the country meet international standards and are safe for use. The regulations also provide for the inspection of exported medicines to ensure that they meet international standards.

The Malawi government has taken a significant step towards ensuring the quality and safety of medicines available in the country. The new regulations on medicine imports and exports are expected to improve the regulatory framework for the pharmaceutical industry and protect public health. The effective implementation of these regulations will depend on the availability of adequate resources to enable the regulator to enforce them effectively.

Key points

  • The regulations introduce mandatory inspections of imported medicines and designate seven border points for pharmaceutical products.
  • Only authorized pharmacists and businesses can import or export medicines under the new regulations.
  • The regulations prescribe penalties of up to K5 million and imprisonment of up to five years for specified offenses.

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.